|Posted by Brazosport Local Section PR Management on November 7, 2017 at 8:15 PM|
Jim Simon has been chosen for the Outstanding Technical Achievement Award in recognition of his innovative work in the field of radiopharmaceuticals. His work on Sm-153- and Ho-166- based bone cancer and bone marrow ablation agents promises relief for many from the debilitating effects of cancer. The novel methods he developed to help move the products of clients companies to fruition, including radiopharmaceuticals based on Ac-225, Sn-117m, In-111, Tc-99m, Lu-177, Y-90, Sr-89, I-125, I-131 and Zr-89 are noteworthy.
Jim's research is aligned with the aCS mission to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and its people.
Jim and his accomplishments will be celebrated at the Brazosport ACS Local Section Award Banquet.